These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1942 related articles for article (PubMed ID: 28920958)

  • 1. The N
    Vu LP; Pickering BF; Cheng Y; Zaccara S; Nguyen D; Minuesa G; Chou T; Chow A; Saletore Y; MacKay M; Schulman J; Famulare C; Patel M; Klimek VM; Garrett-Bakelman FE; Melnick A; Carroll M; Mason CE; Jaffrey SR; Kharas MG
    Nat Med; 2017 Nov; 23(11):1369-1376. PubMed ID: 28920958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.
    Yankova E; Blackaby W; Albertella M; Rak J; De Braekeleer E; Tsagkogeorga G; Pilka ES; Aspris D; Leggate D; Hendrick AG; Webster NA; Andrews B; Fosbeary R; Guest P; Irigoyen N; Eleftheriou M; Gozdecka M; Dias JML; Bannister AJ; Vick B; Jeremias I; Vassiliou GS; Rausch O; Tzelepis K; Kouzarides T
    Nature; 2021 May; 593(7860):597-601. PubMed ID: 33902106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter-bound METTL3 maintains myeloid leukaemia by m
    Barbieri I; Tzelepis K; Pandolfini L; Shi J; Millán-Zambrano G; Robson SC; Aspris D; Migliori V; Bannister AJ; Han N; De Braekeleer E; Ponstingl H; Hendrick A; Vakoc CR; Vassiliou GS; Kouzarides T
    Nature; 2017 Dec; 552(7683):126-131. PubMed ID: 29186125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
    Wang XS; He JR; Yu S; Yu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Jun; 40(3):308-314. PubMed ID: 29978784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N
    Cheng Y; Xie W; Pickering BF; Chu KL; Savino AM; Yang X; Luo H; Nguyen DT; Mo S; Barin E; Velleca A; Rohwetter TM; Patel DJ; Jaffrey SR; Kharas MG
    Cancer Cell; 2021 Jul; 39(7):958-972.e8. PubMed ID: 34048709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA N
    Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
    Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific requirement for Mettl3-dependent m
    Lee H; Bao S; Qian Y; Geula S; Leslie J; Zhang C; Hanna JH; Ding L
    Nat Cell Biol; 2019 Jun; 21(6):700-709. PubMed ID: 31061465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
    Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
    Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m
    Sang L; Wu X; Yan T; Naren D; Liu X; Zheng X; Zhang N; Wang H; Li Y; Gong Y
    J Cancer; 2022; 13(3):1019-1030. PubMed ID: 35154467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of RNA Methyltransferase
    Wu X; Ye W; Gong Y
    Front Oncol; 2022; 12():873903. PubMed ID: 35574332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia.
    Pan ZP; Wang B; Hou DY; You RL; Wang XT; Xie WH; Huang HF
    FEBS Open Bio; 2021 Jun; 11(6):1659-1672. PubMed ID: 33932138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic m
    Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
    Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a PROTAC degrader for METTL3-METTL14 complex.
    Du W; Huang Y; Chen X; Deng Y; Sun Y; Yang H; Shi Q; Wu F; Liu G; Huang H; Ding J; Huang X; Xu S
    Cell Chem Biol; 2024 Jan; 31(1):177-183.e17. PubMed ID: 38194973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
    Li D; Cai L; Meng R; Feng Z; Xu Q
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy.
    Liao X; Cai D; Liu J; Hu H; You R; Pan Z; Chen S; Xu K; Dai W; Zhang S; Lin X; Huang H
    Cell Death Dis; 2023 Dec; 14(12):796. PubMed ID: 38052820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.
    Wang A; Chen Y; Shi L; Li M; Li L; Wang S; Wang C
    J Transl Med; 2022 Jun; 20(1):288. PubMed ID: 35761379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mettl3-mediated m
    Xu B; Li Q; Wu Y; Wang H; Xu J; Liu H; Xuan A
    FASEB J; 2022 Jul; 36(7):e22392. PubMed ID: 35716070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.